Effect of intravenous lidocaine dose on pain upon awakening in pediatric tonsillectomy: A randomized trial

Yang Hu,Ming Cheng Du,Yi Chen,Xiang Long,Jing Jing Jiang,yuan gong
DOI: https://doi.org/10.1101/2024.06.21.24309278
2024-06-21
Abstract:We investigated the potential of intravenous lidocaine to reduce pain on awakening in a dose-dependent manner and aimed to determine the median effective dose of lidocaine in 200 children aged 3–12 years (American Society of Anesthesiologists physical status I–II) who underwent elective tonsillectomy with or without adenoidectomy at Yichang Central People’s Hospital. The patients were randomized into four dose groups (A–D: 0.0, 1.0, 1.5, and 2.0 mg/kg, respectively), and they underwent the same anesthetic induction and maintenance protocols. The primary outcome was pain on awakening, while secondary outcomes included pain scores at 1, 4, 12, and 24 h after awakening; incidences of laryngospasm, bronchospasm, or perioperative stridor; and time to extubation. Intraoperative cardiac events were classified as safety events. Our findings indicated that intravenous lidocaine dose-dependently reduced pain on awakening, with the median effective dose being 1.75 mg/kg. Significant differences were observed between groups A and D (P ≤ 0.001). No incidents of laryngospasm, bronchospasm, or perioperative stridor were observed. Furthermore, there were significant between-group differences in time to extubation (P ≤ 0.05). In conclusion, our study demonstrated that lidocaine dose-dependently reduced pain on awakening in children undergoing tonsillectomy with or without adenoidectomy, with no severe adverse events.
What problem does this paper attempt to address?
The aim of this paper is to investigate the effect of intravenous lidocaine on awakening pain after tonsillectomy (with or without adenoidectomy) in children and to determine its effective dose. Specifically, the study aims to explore whether different doses of intravenous lidocaine can reduce awakening pain in children postoperatively in a dose-dependent manner and to find the 50% effective dose (ED50). The study included a total of 200 children aged 3 to 12 years, who were randomly divided into four groups to receive lidocaine doses of 0.0, 1.0, 1.5, and 2.0 mg/kg, respectively. The primary outcome was the pain score during the awakening period, and secondary outcomes included pain scores at 1 hour, 4 hours, 12 hours, and 24 hours postoperatively, as well as the incidence of laryngospasm, bronchospasm, or perioperative wheezing, and extubation time. The study found that intravenous lidocaine does indeed reduce awakening pain in a dose-dependent manner, with an ED50 of 1.75 mg/kg. Additionally, no serious adverse events were observed.